Dynamic contrast-enhanced magnetic resonance imaging can improve diagnostic accuracy of detecting bladder carcinoma in situ in combination with photodynamic diagnosis?
Main Authors: | M. Miyake, N. Marugami, S. Hori, N. Nishimura, T. Owari, Y. Itami, Y. Nakai, N. Tanaka, K. Fujimoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320334972 |
Similar Items
-
A Potential Application of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined with Photodynamic Diagnosis for the Detection of Bladder Carcinoma in Situ: Toward the Future ‘MRI-PDD Fusion TURBT’
by: Makito Miyake, et al.
Published: (2019-09-01) -
Non-fiber type collagens in voided urine supernatant are detection and prognostic markers in non-muscle invasive bladder cancer
by: M. Miyake, et al.
Published: (2020-07-01) -
The supplementary GM-CSF to neoadjuvant gemicitabine-cisplatin systemic chemotherapy plus PD-L1 blockade decrease local tumor recurrence of urothelial carcinoma after surgery via suppression of MDSCs in blood and tumor microevironment
by: M. Miyake, et al.
Published: (2020-07-01) -
Down-grading of ipsilateral hydronephrosis by neoadjuvant chemotherapy is associated with better oncological outcomes after radical nephroureterectomy in patients with ureteral cancer
by: M. Miyake, et al.
Published: (2020-07-01) -
Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma
by: Miyake M, et al.
Published: (2018-12-01)